Guido Reber

University Hospital of Geneva — Switzerland

Medicine · Health Sciences

44h-index14.3kcitations168works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Venous Thromboembolism Diagnosis and Management(52), Systemic Lupus Erythematosus Research(46), Blood Coagulation and Thrombosis Mechanisms(34), Monoclonal and Polyclonal Antibodies Research(28), Platelet Disorders and Treatments(24)

Publications168 total

Felty's syndrome and hypofibrinogenemia: an unusual target for anti-cyclic citrullinated peptide antibodies?
Modern Rheumatology·2013· 2 cited
Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study
Thrombosis Journal·2013· 24 citedOpen Access
Standardization of D‐dimer Testing
2013· 14 cited
Acquired factor XIII deficiency: a therapeutic challenge
Thrombosis and Haemostasis·2013· 54 cited
P146 TLR2-ligands induce NF-κB activation exclusively from endosomal compartments
Cytokine·2012
<i>In</i> ECAT <i>veritas?</i>
Lupus·2012· 20 cited
Inflammatory and Prothrombotic States in Obese Children of European Descent
Obesity·2012· 48 citedOpen Access
SPECIAL ARTICLE In ECAT veritas
2012
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests
Thrombosis Research·2011· 138 cited
Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies
Blood·2011· 106 cited
A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family
Blood Coagulation & Fibrinolysis·2011· 11 cited
An international multicentre‐laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti‐beta2‐glycoprotein autoantibodies
Journal of Thrombosis and Haemostasis·2010· 51 citedOpen Access
57 Acquired factor XIII inhibitor: multimodal therapeutic approach with finally including immunoadsorption
Transfusion and Apheresis Science·2010
Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome
Journal of Thrombosis and Haemostasis·2010· 68 cited
Anti-apolipoprotein A-1 autoantibodies as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction
Annals of the Rheumatic Diseases·2010Open Access
Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction
European Heart Journal·2010· 86 cited
[Evaluating the biological efficacy of clopidogrel: genotype or phenotype?].
PubMed·2010· 1 cited
New oral antithrombotics: a need for laboratory monitoring. Against
Journal of Thrombosis and Haemostasis·2010· 67 cited
Evaluation de [b]l’efficacité[/b] biologique du clopidogrel : génotype ou phénotype ?
Revue Médicale Suisse·2010
La recherche des facteurs biologiques de risque établis de maladie thromboembolique veineuse : état des connaissances et conséquences pour la pratique en biologie clinique
Sang thrombose vaisseaux·2009· 12 cited
page 1 of 9Next →

Frequent Co-authors

Philippe de Moerloose(27), Henri Bounameaux(11), P de Moerloose(9), Marielle Sanmarco(8), Anǵela Tincani(7), Françoise Boehlen(6), Arnaud Perrier(5), J Arvieux(5), Egbert K. O. Kruithof(5), Marie‐Claire Boffa(4), Philip G. de Groot(3), Sylvie Dunoyer-Geindre(3), Nathalie Satta(3), Nicolas Vuilleumier(3), Pascale Roux‐Lombard(3), R. H. W. M. Derksen(2), Pier Luigi Meroni(2), Daniel O. Slosman(2), Claudine Caron(2), Sylvie Desmarais(2)